# StimCell Energetics Inc. (STME) · Edgar & Edgarette company card

> StimCell Energetics (STME) saw revenue fall 100% in FY2024 to $0 million, equity -1792% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1493712 · fiscal year ended 2024-05-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/STME) · [JSON](https://www.pops4.com/boards/company/STME.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $0 |
| Revenue growth, 1 year | -100.0% |
| Revenue growth per year | — |
| Operating margin | — |
| Net margin | -Infinity% |
| Operating cash flow | −$145,898 |
| Capital spending | — |
| Free cash flow | — |
| Cash | $43,415 |
| Long-term debt | — |
| Total assets | $46,122 |
| Total equity | −$826,455 |
| Equity ÷ assets | -1791.9% |
| Return on equity | — |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Piotroski F: 3 of 9 (middling)
- Health Harbor boat: Old boat · three warning signs · filed late quarterly report notice in the last 12 months; liabilities exceed assets (often from years of share buybacks, not always distress); operating cash flow was negative (-$312K in FY2026)

## Edgarette's reading

Exposure: revenue $0K (FY2024). Experience: revenue down 100.0% on the year. Soundness: equity -1791.9% of assets (liabilities exceed assets). Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $0K and $0K next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): growth -100.0% against 11.6%.

## Health Watch, last 12 months

- Item NT 10-Q Late quarterly report notice: 1, latest 2026-01-15 ([filing](https://www.sec.gov/Archives/edgar/data/1493712/000149371226000002/0001493712-26-000002-index.htm))

## Recent filings

- 10-Q · filed 2026-10-14 · [filing](https://www.sec.gov/Archives/edgar/data/1493712/000149371226000014/0001493712-26-000014-index.htm)
- 8-K · filed 2026-09-08 · 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1493712/000149371226000012/0001493712-26-000012-index.htm)
- 10-K · filed 2026-08-31 · [filing](https://www.sec.gov/Archives/edgar/data/1493712/000149371226000010/0001493712-26-000010-index.htm)
- 10-Q · filed 2026-04-10 · [filing](https://www.sec.gov/Archives/edgar/data/1493712/000149371226000008/0001493712-26-000008-index.htm)
- 8-K · filed 2026-03-20 · 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1493712/000149371226000006/0001493712-26-000006-index.htm)
- 10-Q · filed 2026-01-15 · [filing](https://www.sec.gov/Archives/edgar/data/1493712/000149371226000004/0001493712-26-000004-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001493712.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1493712

## Cite

POPS4, Edgar & Edgarette: StimCell Energetics Inc. (STME) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/STME. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Its latest audited year is FY2026, which reports no revenue; the revenue figures and the range here are from FY2024, its last year with revenue on record. Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.